Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020

IMPORTANCE: Buprenorphine has been approved for opioid use disorder treatment, yet remains underutilized. Cost may present a barrier; little is known about how out-of-pocket costs vary. OBJECTIVE: To determine if out-of-pocket costs and prescription characteristics for buprenorphine varied by type o...

Descripción completa

Detalles Bibliográficos
Autores principales: Strahan, Andrea E., Desai, Shaina, Zhang, Kun, Guy, Gery P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918874/
https://www.ncbi.nlm.nih.gov/pubmed/36763363
http://dx.doi.org/10.1001/jamanetworkopen.2022.54590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918874/
https://www.ncbi.nlm.nih.gov/pubmed/36763363
http://dx.doi.org/10.1001/jamanetworkopen.2022.54590

Ejemplares similares